Autoimmune hepatitis laboratory findings
|
Autoimmune hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autoimmune hepatitis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Autoimmune hepatitis laboratory findings |
|
Risk calculators and risk factors for Autoimmune hepatitis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Manpreet Kaur, MD [2]
Overview
Laboratory findings consistent with the diagnosis of autoimmune hepatitis include, increased serum aminotransferase levels (1.5-50 times reference values), Increased serum immunoglobulin levels, primarily immunoglobulin G (1.2 to 3.0 times normal) and seropositive for ANAs, anti-actin, SMAs, LKM-1, anti-liver cytosol 1 (anti-LC1) antibodies, SLA/LP autoantibodies or pANCA.
Laboratory Findings
Following laboratory tests are used to diagnose autoimmune hepatitis:
- Liver function tests
- Alkaline phosphatase
- Antibody assays
- Serum protein and immunoglobulins
- Complete blood count and differential count
- Platelet count
- ESR
- Coombs test
- Peripheral blood film
Laboratory findings consistent with the diagnosis of autoimmune hepatitis include:
- Increased serum aminotransferase levels (1.5-50 times reference values)
- Increased serum immunoglobulin levels, primarily immunoglobulin G (1.2 to 3.0 times normal)
- Seropositive for ANAs, anti-actin, SMAs, LKM-1, anti-liver cytosol 1 (anti-LC1) antibodies, SLA/LP autoantibodies or pANCA
| Revised Scoring System of the International Autoimmune Hepatitis Group | |
|---|---|
| Laboratory Findings | Points |
|
+2 0 -2 |
|
+3 +2 +1 0 | |
|
+3 +2 +1 0 | |
|
-4 |
|
-3 +3 |
|
-4
+1 |
|
+2
-2 |
|
+3 +1 +1 -3 -3 -5 | |
|
+2 |
|
+2 |
| +1 | |
|
+2
+3 |
| |
| AP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; IgG, immunoglobulin G; ULN-upper limit of the normal range; HLA, human leukocyte antigen; ANA, antinuclear antibodies; SMA, smooth muscle antibodies; anti-LKM1, antibodies to liver kidney microsome type 1; AMA, antimitochondrial antibodies. Adapted from Alvarez F, et al. J Hepatol 1999;31:929–938, with permission of Elsevier BV and the European Association for the Study of the Liver.[1][2][3] | |
Diagnostic features of the overlap syndromes of autoimmune hepatitis :[4]
| Diagnostic features of the overlap syndromes of autoimmune hepatitis | ||
|---|---|---|
| Type of overlap syndrome | Laboratory features | Serological features |
| AIH-PBC | Serum alkaline phosphatase (AP) level ≥2-fold upper limit of normal range (ULN) | AMA positive |
| AIH-PSC | AST/ALT>ULN
γ-globulin and IgG >ULN |
AMA negative |
| AIH-cholestatic syndrome | AST/ALT>ULN
AP or GGT >ULN |
AMA negative |
References
- ↑ Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde KH, Zeniya M (1999). "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis". J. Hepatol. 31 (5): 929–38. PMID 10580593.
- ↑ Czaja AJ (2008). "Performance parameters of the diagnostic scoring systems for autoimmune hepatitis". Hepatology. 48 (5): 1540–8. doi:10.1002/hep.22513. PMID 18924244.
- ↑ Wiegard C, Schramm C, Lohse AW (2009). "Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future". Semin. Liver Dis. 29 (3): 254–61. doi:10.1055/s-0029-1233532. PMID 19675998.
- ↑ Kuiper EM, Zondervan PE, van Buuren HR (2010). "Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome". Clin. Gastroenterol. Hepatol. 8 (6): 530–4. doi:10.1016/j.cgh.2010.03.004. PMID 20304098.